Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
NU E Power Corp. Announces Closing of Non-Brokered Private Placement for $1.7 Million. (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News OraSure Technologies Inc OSUR

Healthcare
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic and specimen collection devices and products in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid... see more

Recent & Breaking News (NDAQ:OSUR)

OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital

GlobeNewswire 6 days ago

Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors

Business Wire 6 days ago

OraSure Submits CT/NG Molecular Self-Test and Colli-Pee(TM) Urine Collection Device for FDA Review

GlobeNewswire January 5, 2026

OraSure Technologies Issues Statement Regarding Altai Capital's Intent to Nominate Director Candidates

GlobeNewswire December 17, 2025

Altai Capital Management Announces Intention to Nominate Two Highly-Qualified Candidates for Election to OraSure Board of Directors

Business Wire December 17, 2025

OraSure to Participate in Upcoming Investor Conference

GlobeNewswire November 17, 2025

OraSure Announces Third Quarter 2025 Financial Results

GlobeNewswire November 5, 2025

OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th

GlobeNewswire October 29, 2025

OraSure Technologies Appoints Steven K. Boyd to its Board of Directors

GlobeNewswire October 28, 2025

OraSure Announces Second Quarter 2025 Financial Results

GlobeNewswire August 5, 2025

OraSure Appoints Anne Messing as Chief Commercial Officer

GlobeNewswire August 4, 2025

OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th

GlobeNewswire July 21, 2025

OraSure Launches Novel Blood Collection Device for Proteomic Research

GlobeNewswire July 10, 2025

OraSure Announces First Quarter 2025 Financial Results

GlobeNewswire May 7, 2025

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

GlobeNewswire April 23, 2025

OraSure Announces $40 Million Stock Repurchase Program

GlobeNewswire March 24, 2025

OraSure Reports Fourth Quarter 2024 Financial Results

GlobeNewswire February 25, 2025

OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th

GlobeNewswire February 14, 2025

OraSure to Present at the J.P Morgan Healthcare Conference

GlobeNewswire January 7, 2025

CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents

GlobeNewswire January 7, 2025

Podcasts